In the above screening, we focused on HIPK2 because low HIPK2 expression is associated with poor prognosis in pancreatic cancer, and HIPK2 is associated with tumor suppressor p53, one of the major molecules underlying PDAC tumorigenesis. The gene discussed is TP53; the disease is familial pancreatic carcinoma.